Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: The national South African prevention of mother to child evaluation cohort study

Vundli, RamakoloKuhn, LouiseLombard, Carl2023-03-282023-03-282022Vundli, R. et al. (2022). Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study. BMC Infectious Diseases, 22(1), pp.1-14. https://doi.org/10.1186/s12879-022-07847-9https://doi.org/10.1186/s12879-022-07847-91471-2334http://hdl.handle.net/10566/8668Background: The relationship between in-utero antiretroviral (ARV) drug exposure and child growth needs further study as current data provide mixed messages. We compared postnatal growth in the first 18-months of life between children who are HIV-exposed uninfected (CHEU) with fetal exposure to ARV drugs (prophylaxis or triple-drug therapy (ART)) and CHEU not exposed to ARVs. We also examined other independent predictors of postnatal growth.enHIVSouth AfricaChild growthPublic healthAntenatal antiretroviral drugImpact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: The national South African prevention of mother to child evaluation cohort studyArticle